JBM (Healthcare) Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1090B1077
HKD
2.67
-0.01 (-0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
520.32
406.14
397.16
381.54
307.51
264.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
520.32
406.14
397.16
381.54
307.51
264.33
Raw Material Cost
332.40
263.84
216.22
211.43
149.84
130.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
89.02
70.99
74.20
67.30
48.39
45.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.21
6.41
7.41
0.84
1.39
1.73
Selling and Distribution Expenses
120.15
105.94
110.03
119.17
95.16
82.65
Other Expenses
-9.72
-7.74
-8.16
-6.81
-4.95
-4.75
Total Expenditure (Excl Depreciation)
452.55
369.78
326.25
330.59
245.23
213.18
Operating Profit (PBDIT) excl Other Income
67.8
36.4
70.9
50.9
62.300000000000004
51.2
Other Income
14.18
5.08
1.25
8.09
4.24
2.40
Operating Profit (PBDIT)
125.58
89.23
115.77
94.90
96.20
83.37
Interest
8.21
6.41
7.41
0.84
1.39
1.73
Exceptional Items
5.09
-2.50
-21.89
-7.19
0.00
0.00
Gross Profit (PBDT)
187.92
142.30
180.94
170.12
157.68
133.81
Depreciation
43.63
47.78
43.60
35.86
29.68
29.82
Profit Before Tax
78.83
32.54
42.87
51.00
65.13
51.82
Tax
13.57
7.42
11.06
9.67
10.58
7.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
57.09
24.62
22.60
41.02
52.46
42.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
57.09
24.62
22.60
41.02
52.46
42.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.24
-1.29
8.02
3.27
6.81
1.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
63.33
23.33
30.62
44.30
59.27
43.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.0
0.0
0.0
Reserves
985.51
929.20
904.71
657.33
147.64
97.17
Earnings per share (EPS)
0.06
0.03
0.03
0.0
0.0
0.0
Diluted Earnings per share
0.06
0.03
0.03
0.0
0.0
0.0
Operating Profit Margin (Excl OI)
13.02%
8.95%
17.85%
13.35%
20.25%
19.35%
Gross Profit Margin
23.54%
19.78%
21.77%
22.77%
30.83%
30.89%
PAT Margin
10.97%
6.06%
5.69%
10.75%
17.06%
16.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is 28.12% vs 2.24% in Mar 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2023 is 171.67% vs -23.86% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is 32.46% vs -26.55% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is 28.12% vs -13.51% in Mar 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2023 has improved from Mar 2022

Compare Annual Results Of JBM (Healthcare) Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
520.32
1,785.58
-1,265.26
-70.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
520.32
1,785.58
-1,265.26
-70.86%
Raw Material Cost
332.40
1,038.41
-706.01
-67.99%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
89.02
471.31
-382.29
-81.11%
Power Cost
0
0
0.00
Manufacturing Expenses
8.21
67.44
-59.23
-87.83%
Selling and Distribution Expenses
120.15
426.90
-306.75
-71.86%
Other Expenses
-9.72
-53.76
44.04
81.92%
Total Expenditure (Excl Depreciation)
452.55
1,466.48
-1,013.93
-69.14%
Operating Profit (PBDIT) excl Other Income
67.77
319.10
-251.33
-78.76%
Other Income
14.18
57.27
-43.09
-75.24%
Operating Profit (PBDIT)
125.58
560.83
-435.25
-77.61%
Interest
8.21
67.44
-59.23
-87.83%
Exceptional Items
5.09
34.39
-29.30
-85.20%
Gross Profit (PBDT)
187.92
747.17
-559.25
-74.85%
Depreciation
43.63
184.46
-140.83
-76.35%
Profit Before Tax
78.83
343.31
-264.48
-77.04%
Tax
13.57
56.55
-42.98
-76.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
57.09
251.04
-193.95
-77.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
57.09
251.04
-193.95
-77.26%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
6.24
32.16
-25.92
-80.60%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
63.33
283.21
-219.88
-77.64%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
985.51
2,736.69
-1,751.18
-63.99%
Earnings per share (EPS)
0.06
0.13
-0.07
-53.85%
Diluted Earnings per share
0.06
0.13
-0.07
-53.85%
Operating Profit Margin (Excl OI)
13.02%
17.87%
0.00
-4.85%
Gross Profit Margin
23.54%
29.56%
0.00
-6.02%
PAT Margin
10.97%
14.06%
0.00
-3.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 52.03 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 28.12% vs 2.24% in Mar 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 6.33 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 171.67% vs -23.86% in Mar 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.14 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 32.46% vs -26.55% in Mar 2022

Annual - Interest
Interest 0.82 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 28.12% vs -13.51% in Mar 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.02%
in Mar 2023

Figures in %
stock-summary

YoY Growth in year ended Mar 2023 has improved from Mar 2022